UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$574.24 USD
+8.95 (1.58%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $573.12 -1.12 (-0.20%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$574.24 USD
+8.95 (1.58%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $573.12 -1.12 (-0.20%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Zacks Industry Outlook Highlights: Triple-S Management, Anthem, UnitedHealth Group and Select Medical Holdings
by Zacks Equity Research
Zacks Industry Outlook Highlights: Triple-S Management, Anthem, UnitedHealth Group and Select Medical Holdings
Demographic Changes, Diversification Aid Health Insurers
by Zacks Equity Research
Revenues from the managed-care plans of Medicare Advantage are expected to grow significantly as baby boomers retire.
Health Insurance Industry Stock Outlook - Sept. 2017
by Zacks Equity Research
Investing in growing health services business, product diversification, instituting changes in an effort to become more consumer-centric, and investments in technology have helped these companies reap hidden opportunities.
5 Reasons Why You Should Add UnitedHealth to Your Portfolio
by Zacks Equity Research
Solid operating performance, a robust business model, immunity to regulatory uncertainty and a strong earnings outlook make the stock of UnitedHealth (UNH) an attractive one.
Health Care Stocks in Focus as Repeal & Replace Gains Steam
by Zacks Equity Research
Healthcare stocks are jittery due to the regulatory uncertainty that the Graham-Cassidy bill may bring along.
Public Exchange Woes Hit Health Insurers: Stocks in Focus
by Zacks Equity Research
The U.S private health insurers have been incurring mounting losses from the health insurance marketplace. This has led many of them to pull back participation, worsening the scenario for underprivileged Americans.
Inovalon Holdings' ONE Platform Chosen by UnitedHealthcare
by Zacks Equity Research
Inovalon Holding (INOV) will be able to expand in the population health management space through the selection of its proprietary ONE Platform by UnitedHealthcare.
UnitedHealth (UNH) Scales a 52-Week High on Recent Deals
by Zacks Equity Research
UnitedHealth's (UNH) shares are riding on its recent acquisition announcements.
Cigna Shares (CI) Up 38% This Year: Is Further Upside Left?
by Zacks Equity Research
A mix of factors, ranging from industry to company-specific, are favoring the stock of Cigna (CI), driving solid returns.
UnitedHealth to Buy Advisory Board's Health Care Business
by Zacks Equity Research
The acquisition of Advisory Board's health care business will bolster UnitedHealth's (UNH) health management business.
Humana (HUM) Hits 52-Week High on Solid Q2, Raised Outlook
by Zacks Equity Research
Humana's (HUM) shares have been favored by its strong earnings performance, guidance raise and completion of accelerated share buyback.
UnitedHealth (UNH) Up 2.4% Since Earnings Report: Can It Continue?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth Appoints New CEO, Hemsley Takes On New Role
by Zacks Equity Research
UnitedHealth (UNH) promotes internal candidate to the role of new CEO. Current CEO assumes new responsibility.
Envision Healthcare (EVHC) Q2 Earnings Beat, '17 View Cut
by Zacks Equity Research
Envision Healthcare's (EVHC) strong second-quarter earnings were driven by revenue growth in the Physician Services segment, partly offset by an increase in operating expenses.
Select Medical (SEM) Q2 Earnings Top Estimates, Revises View
by Zacks Equity Research
Select Medical's (SEM) solid Q2 results were driven by the strong performance of all segments.
WellCare Health (WCG) Beats on Q2 Earnings and Revenues
by Zacks Equity Research
Wellcare Health (WCG) reported strong results in the second quarter supported by solid performance across its all three business lines and the acquisitions of Universal American and Care1st Arizona
The Ensign Group (ENSG) Q2 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
The Ensign Group's (ENSG) second-quarter earnings missed expectations owing to higher expenses.
Aetna (AET) Tops Q2 Earnings, Revenues, Raises 2017 Guidance
by Zacks Equity Research
Aetna's (AET) strong second-quarter 2017 results were largely driven by improved expense ratio.
Teladoc (TDOC) Q2 Loss Wider than Expected, Revenues Up Y/Y
by Zacks Equity Research
Teladoc's (TDOC) second-quarter loss was wider than expected due to higher expenses.
Molina Healthcare (MOH) Incurs Loss in Q2, Revenues Beat
by Zacks Equity Research
Molina Healthcare (MOH) incurred loss in the second-quarter 2017 owing to higher medical care costs.
Community Health (CYH) Q2 Loss Narrower than Expected (Revised)
by Zacks Equity Research
Community Health's (CYH) second-quarter loss was narrower than expected on lower expenses.
Humana (HUM) Beats Earnings Estimates, Lags Revenues in Q2
by Zacks Equity Research
Humana's (HUM) second-quarter earnings were driven by higher revenues.
LifePoint Health (LPNT) Q2 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
LifePoint Health's (LPNT) second-quarter earnings were driven by lower expenses.
Community Health Systems (CYH) Beats Q2 Earnings Estimates
by Zacks Equity Research
Community Health 's (CYH) second-quarter earnings were driven by lower expenses.
The Zacks Analyst Blog Highlights: Bank of America, UnitedHealth, Intel, UPS and Celgene
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bank of America, UnitedHealth, Intel, UPS and Celgene